The metabolic syndrome in HIV

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 3, 2011, Pages 479-486

  Worm, Signe W ^a   Lundgren, Jens D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

antiretroviral therapy; cardiovascular disease; HIV; metabolic syndrome; risk factors

Indexed keywords

ANTIRETROVIRUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79958286041     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2010.10.018     Document Type: Review

References (67)

1. G.M. Reaven Banting Lecture 1988. Role insulin resistance human diseaseRole insulin resistance Human Disease. 1988 Nutrition 13 1997 65
2. Executive summary of the third report of the national cholesterol educational program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adult treatment III) Journal Of the American Medical Association 285 2005 2486 2497
3. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetic Medicine 15 1998 539 553 (Pubitemid 28319935)
4. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabetic Medicine 23 2006 469 480
5. B. Balkau, and M.A. Charles Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR) Diabetic Medicine 16 1999 442 443
6. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 365 2005 1415 1428 (Pubitemid 40523737)
7. C.M. Alexander, P.B. Landsman, and S.M. Grundy The influence of age and body mass index on the metabolic syndrome and its components Diabetes Obesity & Metabolism 10 2008 246 250 (Pubitemid 351247341)
8. C.A. Sabin, M.A. d'Arminio, and N. Friis-Moller Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction Clinical Infectious Diseases 46 2008 1101 1110 (Pubitemid 351589879)
9. T.R. Glass, C. Ungsedhapand, and M. Wolbers Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study HIV medications 7 2006 404 410 (Pubitemid 44123252)
10. S.W. Worm, N. Friis-Moller, M. Bruyand, M.A. d'Arminio, M. Rickenbach, and P. Reiss High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome Acquired Immune Deficiency Syndrome 24 2010 427 435
11. K. Samaras, H. Wand, and M. Law Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia Diabetes Care 30 2007 113 119 (Pubitemid 46052508)
12. H. Wand, A. Calmy, and D.L. Carey Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection Acquired Immune Deficiency Syndrome 21 2007 2445 2453 (Pubitemid 350145176)
13. P. Bonfanti, C. Giannattasio, and E. Ricci HIV and metabolic syndrome: a comparison with the general population Journal of Acquired Immune Deficiency Syndromes 45 2007 426 431 (Pubitemid 47057669)
14. C. Jerico, H. Knobel, and M. Montero Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors Diabetes Care 28 2005 132 137 (Pubitemid 40095795)
15. B.M. Bergersen, A. Schumacher, and L. Sandvik Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls Scandinavian Journal of Infectious Diseases 38 2006 682 689 (Pubitemid 44144728)
16. D.L. Jacobson, A.M. Tang, and D. Spiegelman Incidence of metabolic syndrome in a cohort of HIV-Infected adults and prevalence relative to the US population (National health and Nutrition Examination Survey) Journal of Acquired Immune Deficiency Syndromes 43 2006 458 466 (Pubitemid 44737105)
17. M.K. Baum, C. Rafie, and S. Lai Coronary heart disease (CHD) risk factors and metabolic syndrome in HIV-Positive drug Users in Miami American journal of Infectious Diseases 2 2006 173 179
18. M.E. Sobieszczyk, D.R. Hoover, and K. Anastos Prevalence and predictors of metabolic syndrome among HIV-Infected and HIV-Uninfected women in the Women's Interagency HIV study Journal of Acquired Immune Deficiency Syndromes 48 2008 272 280
19. C. Gazzaruso, P. Sacchi, and A. Garzaniti Prevalence of metabolic syndrome among HIV patients Diabetes Care 25 2002 1253 1254
20. R. Bruno, C. Gazzaruso, and P. Sacchi High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk Journal of Acquired Immune Deficiency Syndromes 31 2002 363 365 (Pubitemid 35278640)
21. O. Adeyemi, K. Rezai, and M. Bahk Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort AIDS Patient Care STDS 22 2008 941 945
22. K. Falasca, C. Ucciferri, and L. Manzoli Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy International journal of immunopathology and Pharmacology 20 2007 519 527 (Pubitemid 47531055)
23. A. Mangili, D.L. Jacobson, and J. Gerrior Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV Clinical Infectious Diseases 44 2007 1368 1374 (Pubitemid 46717301)
24. V. Estrada, M.T. Martinez-Larrad, J.L. Gonzalez-Sanchez, N.G. de Villar, C. Zabena, and C. Fernandez Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy Metabolism 55 2006 940 945 (Pubitemid 43902897)
25. B.R. Hansen, J. Petersen, and S.B. Haugaard The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy HIV Medications 10 2009 378 387
26. K. Mondy, E.T. Overton, and J. Grubb Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population Clinical Infectious Diseases 44 2007 726 734
27. P. Bonfanti, G.L. De Socio, P. Marconi, M. Franzetti, C. Martinelli, and F. Vichi Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study Current HIV Research 8 2010 165 171
28. D.J. Jevtovic, G. Dragovic, D. Salemovic, J. Ranin, and O. Djurkovic-Djakovic The metabolic syndrome, an epidemic among HIV-infected patients on HAART Biomedicine & Pharmacotherapy 63 2009 337 342
29. G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-Johnsen, and K. Pyorala Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Archives of Internal Medicine 164 2004 1066 1076 (Pubitemid 38668985)
30. V.G. Athyros, E.S. Ganotakis, and M.S. Elisaf Prevalence of vascular disease in metabolic syndrome using three proposed definitions International journal of Cardiology 117 2006 204 210
31. K.J. Hunt, K. Williams, and H.P. Hazuda The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio heart study Annals of Epidemiology 17 2007 870 877 (Pubitemid 47588953)
32. A. Mente, S. Yusuf, S. Islam, M.J. McQueen, S. Tanomsup, and C.L. Onen Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries Journal of the American College of Cardiology 55 21 2010 May 25 2390 2398
33. E. Fontas, L.F. van, and C.A. Sabin Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? Journal of Infectious Diseases 189 2004 1056 1074 (Pubitemid 38373099)
34. M.A. Noor, T. Seneviratne, and F.T. Aweeka Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study Acquired Immune Deficiency Syndrome 16 2002 F1 F8
35. S. De Wit, C. Sabin, and R. Weber Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D: a:D) study Diabetes Care 31 2008 1224 1229
36. B. Ledergerber, H. Furrer, and M. Rickenbach Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study Clinical Infectious Diseases 45 2007 111 119 (Pubitemid 46984626)
37. A. Carr, K. Samaras, D.J. Chisholm, and D.A. Cooper Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance Lancet 351 1998 1881 1883 (Pubitemid 28279721)
38. R. Thiebaut, W.M. El-Sadr, and N. Friis-Moller Predictors of hypertension and changes of blood pressure in HIV-infected patients Antiviral Therapy 10 2005 811 823 (Pubitemid 41652975)
39. E.C. Seaberg, A. Munoz, M. Lu, and R. Detels Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003 Acquired Immune Deficiency Syndrome 19 2005 953 960 (Pubitemid 40834939)
40. J. Eron Jr., P. Yeni, and J. Gathe Jr. The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial Lancet 368 2006 476 482 (Pubitemid 44160731)
41. S.D. Shafran, L.D. Mashinter, and S.E. Roberts The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations HIV Medications 6 2005 421 425 (Pubitemid 41723310)
42. L.F. van, P. Phanuphak, and E. Stroes Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 PLoS Medicine 1 2004 19
43. A. Leon, E. Martinez, and M. Sarasa Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analogues Journal of Antimicrobial Chemotherapy 60 2007 824 830 (Pubitemid 47434262)
44. S.A. Riddler, R. Haubrich, and A.G. DiRienzo Class-sparing regimens for initial treatment of HIV-1 infection New England Journal of Medicine 358 2008 2095 2106 (Pubitemid 351679596)
45. M.A. Noor, J.C. Lo, and K. Mulligan Metabolic effects of indinavir in healthy HIV-seronegative men Acquired Immune Deficiency Syndrome 15 2001 F11 F18
46. G.A. Lee, T. Seneviratne, and M.A. Noor The metabolic effects of lopinavir/ritonavir in HIV-negative men Acquired Immune Deficiency Syndrome 18 2004 641 649 (Pubitemid 38393463)
47. R.R. Sankatsing, R. Franssen, and E. Hassinsk Nevirapine increases high density lipoprotein-cholesterol by stimulation of apolipoprotein AI synthesis Antiviral Therapy 12 Suppl. 2 2007 L5
48. A.N. Phillips, A. Carr, and J. Neuhaus Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial Antiviral Therapy 13 2008 177 187 (Pubitemid 351535369)
49. R.C. Kaplan, L.A. Kingsley, A.R. Sharrett, X. Li, J. Lazar, and P.C. Tien Ten-year predicted coronary heart disease risk in HIV-infected men and women Clinical Infectious Diseases 45 2007 1074 1081 (Pubitemid 47580361)
50. S.E. Dolan, C. Hadigan, and K.M. Killilea Increased cardiovascular disease risk indices in HIV-infected women Journal of Acquired Immune Deficiency Syndromes 39 2005 44 54 (Pubitemid 40617018)
51. T. Joy, H.M. Keogh, and C. Hadigan Relation of body composition to body mass index in HIV-Infected patients with metabolic Abnormalities Journal of Acquired Immune Deficiency Syndromes 2007
52. R. Palacios, J. Santos, and M. Gonzalez Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy International Journal of STD & AIDS 18 2007 184 187 (Pubitemid 351739049)
53. C. Grunfeld, M. Pang, and W. Doerrler Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome Journal of clinical endocrinology and metabolism 74 1992 1045 1052
54. Phillips A, Carr A, Neuhaus J, et al. Interruption of ART and Risk of Cardiovascular Disease: Findings from SMART. 14 th Conference on Retroviruses and Opportunistic Infections (CROI), LA, USA [February 25-27, 2007 # 41]. 2007.
55. W.M. El-Sadr, J.D. Lundgren, J.D. Neaton, F. Gordin, D. Abrams, and R.C. Arduino CD4+ count-guided interruption of antiretroviral treatment New England Journal of Medicine 355 2006 2283 2296 (Pubitemid 44837777)
56. G.V. De Socio, C. Martinelli, E. Ricci, G. Orofino, L. Valsecchi, and P. Vitiello Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study International Journal of STD & AIDS 21 2010 267 272
57. S.W. Worm, C.A. Sabin, and P. Reiss Presence of the metabolic syndrome (MS) is not a better predictor of cardiovascular disease (CVD) than the sum of its components in HIV-infected individuals. Data Collection on Adverse Events of Anti-HIV Drugs (The D: a:D study) Diabetes Care 32 2009 474-480
58. N. Sattar, A. Gaw, and O. Scherbakova Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419 (Pubitemid 36935533)
59. J. Sundstrom, U. Riserus, and L. Byberg Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study British Medical Journal 332 2006 878 882
60. N. Sattar, A. McConnachie, and A.G. Shaper Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies Lancet 371 2008 1927 1935
61. R. Kahn, J. Buse, E. Ferrannini, and M. Stern The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 2005 2289 2304 (Pubitemid 41242486)
62. E.A. Gale Should we dump the metabolic syndrome? Yes British Medical Journal 366 2008 640
63. K.G. Alberti, and P.Z. Zimmet Should we dump the metabolic syndrome? No British Medical Journal 336 2008 641
64. R.K. Simmons, K.G. Alberti, and E.A. Gale The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation Diabetologia 53 2010 600 605
65. S.W. Worm, W.S. De, and R. Weber Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D: a:D Study) Circulation 119 2009 805 811
66. K.M. Anderson, P.W. Wilson, P.M. Odell, and W.B. Kannel An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
67. N. Friis-Moller, R. Thiebaut, and P. Reiss Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study European journal of cardiovascular prevention and Rehabilitation 2010 [epub ahead of print]